Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PLANDENT AS
AS
Active
Org 914768217
Østensjøveien 27, 0661
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1906 · 120 years old
88 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
PLANDENT AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
164M
328M
492M
657M
379M
2021
478M
2022
511M
2023
518M
2024
571M
2025
EBITDA
NOK millions
79M
59M
39M
20M
0M
37M
2021
63M
+70%
2022
50M
-21%
2023
51M
+2%
2024
60M
+18%
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
378 850
478 225
511 261
517 751
570 943
Staff expenses
−57 762
−68 147
−71 333
−75 779
−83 585
EBITDA
37 253
63 357
50 324
51 148
60 030
Depreciation & amort.
−1 288
−1 970
−2 895
−2 412
−2 474
EBIT
35 965
61 388
47 429
48 736
57 556
Net financials
5 815
7 858
6 962
10 593
8 874
Profit before tax
41 781
69 245
54 391
59 329
66 430
Tax
7 638
13 696
10 431
11 516
13 071
Net profit
34 143
55 550
43 960
47 813
53 359
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
310 830
356 651
369 446
404 594
435 786
Equity
169 722
195 272
217 232
243 045
266 405
Long-term debt
52 403
42 214
36 585
37 047
28 627
Short-term debt
88 706
119 165
115 628
124 502
140 754
Total debt
141 108
161 378
152 214
161 549
169 382
Financial ratios
5-year trend
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
2021
2025
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
2021
2025
Return on equity
20.0%
This company
18.4%
Market median
+9% vs market
2021
2025
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
2021
2025
Asset turnover
1.31×
This company
1.12×
Market median
+17% vs market
2021
2025
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
View
PDF
More on PLANDENT AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
